Top Story

Clinical trials accumulate data for novel anti-VEGF

October 21, 2014

CHICAGO — A new anti-VEGF indicated for use in wet age-related macular degeneration achieved clinically meaningful and durable vision improvement in several studies with reduced dosing, according to a speaker here.

Conbercept, a fusion protein produced in a manner similar to Elyea (aflibercept, Regeneron) is approved for use in China, and discussions are underway to bring this drug to the U.S. and other countries, Peter K. Kaiser, MD, told colleagues at the Retina Subspecialty Day preceding the American Academy of Ophthalmology meeting.

Meeting News Coverage

DALK improves vision in eyes with Acanthamoeba keratitis scarring

October 21, 2014
CHICAGO – Deep anterior lamellar keratoplasty showed promise in restoring vision in eyes with significant corneal scarring from Acanthamoeba keratitis, a speaker…
figure Meeting News Coverage

DMEK yields fast visual recovery for endothelial dysfunction

October 21, 2014
CHICAGO — Six-year midterm results showed Descemet’s membrane endothelial keratoplasty for the treatment of endothelial dysfunction provides fast and…
figure Meeting News Coverage

ACA has moderate effect on ophthalmology

October 21, 2014
CHICAGO — The Affordable Care Act has had a modest impact on ophthalmology so far, but a few unknown factors remain, an expert said at the American Academy of…
More News Headlines »
Lindstrom's Perspective Publication Exclusive

Careful planning can still lead to great opportunities in ophthalmology

Ocular Surgery News U.S. Edition, October 10, 2014
Richard L. Lindstrom, MD
Depending on where one touches the elephant, the perception on the current environment and future opportunity for…
More »

When considering new technology, think about the three stakeholders

October 2, 2014
At the upcoming AAO meeting, we will see a variety of new devices and drugs that will excite us, challenge our current…
More »
Meeting News Coverage Video

CorT measures total corneal power

October 19, 2014
CHICAGO – At the Ophthalmology Innovation Summit here, Noel A. Alpins, MD, gives an update on the latest…
More »